Table 1.
Demographic | Value |
---|---|
Age, yr | 41.42±13.03 |
Male:female | 19:15 |
Height, cm | 167.00±7.99 |
Body weight, kg | 36.50±9.87 |
Duration of UC, mo | 51.45±40.28 |
Endoscopic activity index | 7.97±2.71 |
Mayo score | 6.74±2.09 |
Location of lesions | |
Entire colon | 16 |
Rectum and sigmoid colon | 5 |
Left colon | 13 |
Clinical course | |
First onset | 3 |
Chronic | 31 |
UC severity level | |
Mild | 5 |
Moderate | 21 |
Severe | 8 |
Medications | |
First episode | 3 |
Oral 5-ASA or sulphasalazine | 11 |
Corticosteroid, oral or intravenous | 3 |
Oral 5-ASA or sulphasalazine+oral or intravenous steroid | 7 |
Oral 5-ASA or sulphasalazine oral or intravenous steroid+topical 5-ASA | 2 |
Oral 5-ASA or sulphasalazine+enema and oral or intravenous steroid | 1 |
Oral 5-ASA or sulphasalazine+5-ASA enema | 5 |
Enema and oral or intravenous steroid | 1 |
Other | 1 |
Data are presented as mean±SD or number. UC, ulcerative colitis; 5-ASA, 5-aminosalicylic acid.